Home > Topic > Coronavirus Vaccine Tracker

CORONAVIRUS VACCINE TRACKER

Covid-19 vaccine makers assess Omicron response

5 min read . Updated: 29 Nov 2021

Close

A variant-neutral jab has become the next frontier in vaccine development as scientists look at ways to deal with future threats. (AP)

Scientists eye variant-neutral vaccines amid omicron threat

3 min read . Updated: 29 Nov 2021

Close

The World Health Organization added Covaxin to its list of approved emergency use covid-19 vaccines earlier this month. (AP Photo/Altaf Qadri)

Covaxin 50% effective against symptomatic covid-19: Lancet

3 min read . Updated: 25 Nov 2021

Close

The decision comes after a senior UK official said the vaccination programme offered the best opportunity to prevent a re-imposition of restrictions over Christmas (Photo: Reuters)

UK expands covid-19 booster program, Johnson says no need to move to Plan B

1 min read . Updated: 15 Nov 2021

Close

Production delays, high price and storage issues led to private hospitals scaling down demand for Sputnik V vaccine.reuters

Local partners shift focus to producing Sputnik Light vax

3 min read . Updated: 15 Nov 2021

Close

Covaxin is India’s indigenous covid-19 vaccine

Bharat Bio’s Covaxin shows 65.2% efficacy against Delta variant

2 min read . Updated: 12 Nov 2021

Close

A beneficiary receives a dose of the COVID-19 vaccine at Chachaier Home, in Ranchi. (ANI)

UP, Bihar & Jharkhand have given both jabs to less than 17% of their population

3 min read . Updated: 11 Nov 2021

Close

Zydus Cadila is in a position to provide one crore doses of ZyCoV-D per month, company officials are learnt to have conveyed to the ministry.

Centre places purchase order for one crore doses of Zydus Cadila's Covid vaccine

1 min read . Updated: 07 Nov 2021

Close

New Biden vaccine rules don’t allow self-administered, self-reported covid-19 tests

3 min read . Updated: 06 Nov 2021

Close

Moderna has relied entirely on contract manufacturers to put its vaccine into vials, the process known as fill and finish. REUTERS

Moderna finds that inventing a covid vaccine was the easy part

6 min read . Updated: 06 Nov 2021

Close

World Health Organization on Wednesday granted emergency approval to Bharat Biotech’s Covaxin. (HT PHOTO) (HT_PRINT)

Bharat Bio's US partner Ocugen seeks FDA nod for Covaxin use in children

2 min read . Updated: 06 Nov 2021

Close

Covaxin was recently awarded Emergency Use Listing by the World Health Organization. (HT)

Covaxin approval requested in US for ages 2-18 by Bharat Biotech’s US partner

2 min read . Updated: 06 Nov 2021

Close

A health worker administers a dose of the COVID-19 booster vaccine, amid the coronavirus disease (COVID-19) pandemic. (REUTERS)

Are COVID-19 boosters the same as the original vaccines?

1 min read . Updated: 04 Nov 2021

Close

Covaxin has been specifically designed to meet the needs of global distribution chains, the requirements for which are more critical in low- and middle-income countries. (REUTERS)

WHO grants Bharat Bio’s Covaxin shot emergency approval

3 min read . Updated: 04 Nov 2021

Close

Novavax COVID vaccine gets first authorization; expects more within weeks: CEO

2 min read . Updated: 02 Nov 2021

Close

FILE PHOTO: Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant. (REUTERS)

Covaxin emergency use: WHO seeks ‘additional clarifications’ from Bharat Biotech

1 min read . Updated: 27 Oct 2021

Close

Govt in talks with Zydus Cadila for its covid-19 vaccine pricing

2 min read . Updated: 26 Oct 2021

Close

The researchers compared how often neurological complications occurred in set windows of time. (REUTERS)

Covid more likely to cause rare brain conditions than vaccines: Study

1 min read . Updated: 26 Oct 2021

Close

A health worker prepares a dose of the Covid-19 Covaxin vaccine at a vaccination center set up at a Delhi government health dispensary in New Delhi. (Bloomberg)

Covaxin: WHO to consider emergency listing in a meet today

2 min read . Updated: 26 Oct 2021

Close

Moderna released no further details and hasn't submitted its data to a scientific journal but said it plans to share the interim results with the FDA and global regulators soon. (AFP)

Moderna says its low-dose Covid-19 shot works for kids 6 to 11

2 min read . Updated: 26 Oct 2021

Close

×

My Reads Redeem a Gift Card Logout